CD276 and neoplasm: For instance, B7-H3, the key inhibitor of tumor antigen-specific immune response, is increased in hepatocarcinogenesis in the DEN-induced rat model, which is of interest since B7-H3 is considered as an attractive future target for antibody-based immunotherapy [41].